REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2021

Aug 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS, INC. (REGN)
CIK: 0000872589
Period of Report: 2021-08-06

Reporting Person: Landry Robert E (EVP Finance CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-06	Common Stock	M	2000	$381.92	Acquired	27903	Direct
2021-08-06	Common Stock	F	1636	$607.51	Disposed	26267	Direct
2021-08-09	Common Stock	S	1	$610.85	Disposed	26266	Direct
2021-08-09	Common Stock	S	36	$612.97	Disposed	26230	Direct
2021-08-09	Common Stock	S	1	$613.79	Disposed	26229	Direct
2021-08-09	Common Stock	S	66	$614.7	Disposed	26163	Direct
2021-08-09	Common Stock	S	40	$615.42	Disposed	26123	Direct
2021-08-09	Common Stock	S	36	$617.83	Disposed	26087	Direct
2021-08-09	Common Stock	S	58	$618.44	Disposed	26029	Direct
2021-08-09	Common Stock	S	36	$619.7	Disposed	25993	Direct
2021-08-09	Common Stock	S	54	$621.19	Disposed	25939	Direct
2021-08-09	Common Stock	S	36	$623.54	Disposed	25903	Direct
2021-08-09	Common Stock	M	3000	$381.92	Acquired	28903	Direct
2021-08-09	Common Stock	F	2463	$617.68	Disposed	26440	Direct
2021-08-10	Common Stock	S	433	$611.0	Disposed	26007	Direct
2021-08-10	Common Stock	S	50	$612.31	Disposed	25957	Direct
2021-08-10	Common Stock	S	1	$614.09	Disposed	25956	Direct
2021-08-10	Common Stock	S	1	$615.73	Disposed	25955	Direct
2021-08-10	Common Stock	S	45	$618.89	Disposed	25910	Direct
2021-08-10	Common Stock	S	7	$619.19	Disposed	25903	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-06	Non-Qualified Stock Option (right to buy)	$381.92	M	2000	Disposed	2026-12-16	Common Stock (2000)	Direct
2021-08-09	Non-Qualified Stock Option (right to buy)	$381.92	M	3000	Disposed	2026-12-16	Common Stock (3000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	229	Indirect

Footnotes

F1: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2: Represents volume-weighted average price of sales of 36 shares of Company stock on August 9, 2021 at prices ranging from $612.97 to $612.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.

F3: Represents volume-weighted average price of sales of 66 shares of Company stock on August 9, 2021 at prices ranging from $614.34 to $614.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.

F4: Represents volume-weighted average price of sales of 40 shares of Company stock on August 9, 2021 at prices ranging from $615.35 to $615.51. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.

F5: Represents volume-weighted average price of sales of 36 shares of Company stock on August 9, 2021 at prices ranging from $617.73 to $617.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.

F6: Represents volume-weighted average price of sales of 58 shares of Company stock on August 9, 2021 at prices ranging from $618.14 to $618.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.

F7: Represents volume-weighted average price of sales of 36 shares of Company stock on August 9, 2021 at prices ranging from $619.48 to $619.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.

F8: Represents volume-weighted average price of sales of 54 shares of Company stock on August 9, 2021 at prices ranging from $621.02 to $621.40. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.

F9: Represents volume-weighted average price of sales of 36 shares of Company stock on August 9, 2021 at prices ranging from $623.40 to $623.69. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.

F10: Represents volume-weighted average price of sales of 45 shares of Company stock on August 10, 2021 at prices ranging from $618.13 to $618.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.

F11: Represents volume-weighted average price of sales of 7 shares of Company stock on August 10, 2021 at prices ranging from $619.16 to $619.24. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.

F12: The stock option award vests in four equal annual installments, commencing one year after the date of grant.